Skip to content

Apotheek Omnia

Active
Public limited companyfounded 1952active for 74 yearsKoninklijke Baan(Kok) 154, 8670 Koksijde, BelgiumKBO/BCE: BE 0405.813.851

From the official registers: KBO 49 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Omnia has been active since 1952 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €859,867 and a net result of €56,058. Equity has been growing by about 14% per year since 2019. Its solvency ranks better than 80% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
Apotheek OmniaActiveChecked score 95/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 21-01-1952 Normal situation
Legal form
Public limited company
Registered office
Koninklijke Baan(Kok) 154, 8670 Koksijde
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.004.154.216 8670 Koksijde, since 01-01-1952
Financial year end
31 August
Peppol
Reachable since 15-08-2025
Company details

Board and ownership

Board
  • Lindammer CommVDirector · permanent representative Marceau Decru
  • DEMARAX BV BVDirector
  • O.P.S. BV BVDirector
Shareholders
Board & ownership

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts to 31-08-2025
Gross margin
€270,247
▼ 22.1%
Turnover
≈ €980,000
estimated
Profit
€56,058
▼ 41.5%
Equity
€859,867
▲ 7.0%
Total assets
€1.3m
▼ 14.9%
Staff
3 FTE
▼ 11.8%
2025 accounts filed 56 days before the deadline
Filed on 03-02-2026PDF
Financials
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 1952Size: 3 FTE, total assets €1.3mEquity €859,867 (67.4% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 63% of micro companies in retail trade (NACE 47)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Strong
Solvency 92+13
equity 67.4% of total assets
Liquidity 54+1
short-term debt 21.5% · cash 9.0%
Profitability 74-3
return on assets 4.4%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024highest value 01-2025: 0.1%▼ -0.2 percentage points vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026lowest value 05-2026: 0.1%● unchanged vs 04-2026lowest value 06-2026: 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €80,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.75 (2.04 in 2024), above the usual 1.5. Short-term debt is 21.5% and cash 9% of total assets. 32.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 79% of them on solvency, 59% on liquidity, 60% on profitability and 56% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 1952
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: 3 FTE, total assets €1.3m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Equity €859,867 (67.4% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-08-2025 was due by 31-03-2026 and was filed on 03-02-2026, 56 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
56 days early
2024
103 days early
2023
103 days early
2022
105 days early
2021
114 days early
2020
99 days early
2019
137 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 102 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 31-08-2026 is due by 31-03-2027. Nothing is late today. The company usually files around 18 December (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-08-2026 year end01-11-2026 today31-03-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Oldest company in West Flanders, Retail trade sectorin the Checked rankings No. 1 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €56,058 7 years View

Documents

Annual accounts at the NBB

All 49 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Apotheek Omnia

What is the company number of Apotheek Omnia?
The company number of Apotheek Omnia is 0405.813.851. The VAT number is the same number with BE in front: BE 0405.813.851.
Where is Apotheek Omnia based?
The registered office is at Koninklijke Baan(Kok) 154, 8670 Koksijde.Company details
What does Apotheek Omnia do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Omnia?
The legal form of Apotheek Omnia is Public limited company (NV).
When was Apotheek Omnia founded?
Apotheek Omnia was founded on 21-01-1952.
Is Apotheek Omnia still active?
Yes, Apotheek Omnia is an active enterprise in the KBO register.
How many employees does Apotheek Omnia have?
Apotheek Omnia had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Omnia?
The turnover in financial year 2025 is ≈ €980,000. This figure is estimated from the gross margin of €270,247 and 47 comparable companies (NACE 477). It probably lies between €760,000 and €1.6m.
Is Apotheek Omnia profitable?
In financial year 2025, Apotheek Omnia made a profit of €56,058.
Where can I find the annual accounts of Apotheek Omnia?
Apotheek Omnia filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Apotheek Omnia due?
Apotheek Omnia must file the annual accounts for financial year 2026 by 31-03-2027.Timeline

Companies linked to Apotheek Omnia

Comparable companies

These companies have the same main activity as Apotheek Omnia: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €963,000 and €1.7m, founded between 1961 and 1972.

CompanyTotal assetsGross margin
Apotheek Omnia Koksijde€1.3m€0.3m
APOTHEEK CREMERS Gistel€1.3m€0.4m
apotheek Schyvens Vorselaar€1.2m€0.2m
APOTHEEK CLAES Balen€1.0m€0.3m
Pharmacie Dieux Binche€1.3m€0.3m
PHARMACIE DU FAUBOURG Chaudfontaine€1.7m€0.3m
DE FRENCH Ieper€1.0m€0.4m
Full comparison

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure